Nukkleus Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2022	2021	2020	2019
Revenue	21.51	19.29	0	-
Revenue Growth (YoY)	11.54%	-	-	-
Cost of Revenue	22.17	19.37	0	-
Gross Profit	-0.66	-0.08	0	-
Selling, General & Admin	1.58	0.32	0.15	-
Other Operating Expenses	4.59	0.53	0	0
Operating Expenses	6.17	0.85	0.15	-
Operating Income	-6.83	-0.93	-0.15	-
Other Expense / Income	5.01	0	0.17	-
Pretax Income	-11.85	-0.94	-0.32	-
Net Income	-11.85	-0.94	-0.32	-
Shares Outstanding (Basic)	5	6	4	1
Shares Outstanding (Diluted)	5	6	4	-
Shares Change	-25.72%	65.28%	557.01%	-
EPS (Basic)	-0.29	-0.10	-0.09	-
EPS (Diluted)	-0.29	-0.10	-0.09	-
Free Cash Flow	1.62	1.17	-0.14	-0.02
Free Cash Flow Per Share	0.36	0.19	-0.04	-0.04
Gross Margin	-3.07%	-0.43%	-	-
Operating Margin	-31.75%	-4.83%	-	-
Profit Margin	-55.06%	-4.86%	-	-
Free Cash Flow Margin	7.51%	6.05%	-	-
EBITDA	-9.16	-0.47	-0.32	-
EBITDA Margin	-42.55%	-2.42%	-	-
Depreciation & Amortization	2.69	0.47	0	0
EBIT	-11.85	-0.94	-0.32	-
EBIT Margin	-55.06%	-4.86%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).